• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,741.82 238.22
( 0.31%)
Global Indices
Nasdaq
52,357.11 -589.04
(-1.11%)
Dow Jones
7,503.65 -21.20
(-0.28%)
Hang Seng
67,966.49 1,147.44
(1.72%)
Nikkei 225
10,472.08 -16.96
(-0.16%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
506197
INE416D01022
108.9247686
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BLISSGVS
55.04
5399.85
EPS(TTM)
Face Value()
Div & Yield %
9.25
1
0.1
 

Welcast Steels standalone net profit rises 626.32% in the March 2026 quarter
May 20,2026
Net profit of Welcast Steels rose 626.32% to Rs 1.38 crore in the quarter ended March 2026 as against Rs 0.19 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 20.81 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 5.30 crore in the year ended March 2026 as against net loss of Rs 0.34 crore during the previous year ended March 2025. Sales declined 45.67% to Rs 45.82 crore in the year ended March 2026 as against Rs 84.33 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales020.81 -100 45.8284.33 -46
OPM %00.19 --6.31-1.40 -
PBDT2.210.46 380 -0.970.44 PL
PBT2.070.22 841 -1.59-0.35 -354
NP1.380.19 626 -5.30-0.34 -1459